APO Research
Talk to an analyst

APO RESEARCH · REPORT

Furosemide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Furosemide Market Analysis and Forecast 2026-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchFurosemide Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Furosemide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Furosemide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furosemide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Furosemide Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Furosemide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Furosemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Furosemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Furosemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Furosemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Furosemide include Sun Pharm Inds, Sandoz, Sanofi Aventis, Mylan, West-Ward Pharms, US Pharm Holdings, Ivax Sub Teva Pharms, Hospira and Emcure Pharms, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Furosemide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Furosemide, also provides the sales of main regions and countries. Of the upcoming market potential for Furosemide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Furosemide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Furosemide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Furosemide sales, projected growth trends, production technology, application and end-user industry.

Furosemide Segment by Company

Sun Pharm Inds

Sandoz

Sanofi Aventis

Mylan

West-Ward Pharms

US Pharm Holdings

Ivax Sub Teva Pharms

Hospira

Emcure Pharms

Furosemide Segment by Type

Injection

Solution

Tablet

Furosemide Segment by Application

Clinics

Hospital

Pharmacy

Others

Furosemide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furosemide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Furosemide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Furosemide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Furosemide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Furosemide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Solution Major Manufacturers Table 4. Tablet Major Manufacturers Table 5. Global Furosemide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinics Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Pharmacy Major Manufacturers Table 9. Others Major Manufacturers Table 10. Furosemide Industry Trends Table 11. Furosemide Industry Drivers Table 12. Furosemide Industry Opportunities and Challenges Table 13. Furosemide Industry Restraints Table 14. Global Furosemide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Furosemide Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Furosemide Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Furosemide Revenue Market Share by Region (2021-2026) Table 18. Global Furosemide Revenue Market Share by Region (2027-2032) Table 19. Global Furosemide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 20. Global Furosemide Sales by Region (2021-2026) & (tons) Table 21. Global Furosemide Sales by Region (2027-2032) & (tons) Table 22. Global Furosemide Sales Market Share by Region (2021-2026) Table 23. Global Furosemide Sales Market Share by Region (2027-2032) Table 24. Global Furosemide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Furosemide Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Furosemide Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Furosemide Sales Market Share by Manufacturers (2021-2026) Table 28. Global Furosemide Sales Price (US$/kg) of Manufacturers (2021-2026) Table 29. Global Furosemide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Furosemide Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Furosemide Manufacturers, Product Type & Application Table 32. Global Furosemide Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Furosemide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Furosemide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Furosemide Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Furosemide Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Furosemide Revenue Market Share by Type (2021-2026) Table 39. Global Furosemide Revenue Market Share by Type (2027-2032) Table 40. Global Furosemide Sales by Type 2021 VS 2025 VS 2032 (tons) Table 41. Global Furosemide Sales by Type (2021-2026) & (tons) Table 42. Global Furosemide Sales by Type (2027-2032) & (tons) Table 43. Global Furosemide Sales Market Share by Type (2021-2026) Table 44. Global Furosemide Sales Market Share by Type (2027-2032) Table 45. Global Furosemide Price by Type (2021-2026) & (US$/kg) Table 46. Global Furosemide Price by Type (2027-2032) & (US$/kg) Table 47. Global Furosemide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Furosemide Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Furosemide Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Furosemide Revenue Market Share by Application (2021-2026) Table 51. Global Furosemide Revenue Market Share by Application (2027-2032) Table 52. Global Furosemide Sales by Application 2021 VS 2025 VS 2032 (tons) Table 53. Global Furosemide Sales by Application (2021-2026) & (tons) Table 54. Global Furosemide Sales by Application (2027-2032) & (tons) Table 55. Global Furosemide Sales Market Share by Application (2021-2026) Table 56. Global Furosemide Sales Market Share by Application (2027-2032) Table 57. Global Furosemide Price by Application (2021-2026) & (US$/kg) Table 58. Global Furosemide Price by Application (2027-2032) & (US$/kg) Table 59. Sun Pharm Inds Company Information Table 60. Sun Pharm Inds Business Overview Table 61. Sun Pharm Inds Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 62. Sun Pharm Inds Furosemide Product Portfolio Table 63. Sun Pharm Inds Recent Development Table 64. Sandoz Company Information Table 65. Sandoz Business Overview Table 66. Sandoz Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Sandoz Furosemide Product Portfolio Table 68. Sandoz Recent Development Table 69. Sanofi Aventis Company Information Table 70. Sanofi Aventis Business Overview Table 71. Sanofi Aventis Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Sanofi Aventis Furosemide Product Portfolio Table 73. Sanofi Aventis Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Mylan Furosemide Product Portfolio Table 78. Mylan Recent Development Table 79. West-Ward Pharms Company Information Table 80. West-Ward Pharms Business Overview Table 81. West-Ward Pharms Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. West-Ward Pharms Furosemide Product Portfolio Table 83. West-Ward Pharms Recent Development Table 84. US Pharm Holdings Company Information Table 85. US Pharm Holdings Business Overview Table 86. US Pharm Holdings Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. US Pharm Holdings Furosemide Product Portfolio Table 88. US Pharm Holdings Recent Development Table 89. Ivax Sub Teva Pharms Company Information Table 90. Ivax Sub Teva Pharms Business Overview Table 91. Ivax Sub Teva Pharms Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Ivax Sub Teva Pharms Furosemide Product Portfolio Table 93. Ivax Sub Teva Pharms Recent Development Table 94. Hospira Company Information Table 95. Hospira Business Overview Table 96. Hospira Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Hospira Furosemide Product Portfolio Table 98. Hospira Recent Development Table 99. Emcure Pharms Company Information Table 100. Emcure Pharms Business Overview Table 101. Emcure Pharms Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Emcure Pharms Furosemide Product Portfolio Table 103. Emcure Pharms Recent Development Table 104. North America Furosemide Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Furosemide Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Furosemide Sales by Type (2021-2026) & (tons) Table 107. North America Furosemide Sales by Type (2027-2032) & (tons) Table 108. North America Furosemide Sales Price by Type (2021-2026) & (US$/kg) Table 109. North America Furosemide Sales Price by Type (2027-2032) & (US$/kg) Table 110. North America Furosemide Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Furosemide Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Furosemide Sales by Application (2021-2026) & (tons) Table 113. North America Furosemide Sales by Application (2027-2032) & (tons) Table 114. North America Furosemide Sales Price by Application (2021-2026) & (US$/kg) Table 115. North America Furosemide Sales Price by Application (2027-2032) & (US$/kg) Table 116. North America Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Furosemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Furosemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Furosemide Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 120. North America Furosemide Sales by Country (2021-2026) & (tons) Table 121. North America Furosemide Sales by Country (2027-2032) & (tons) Table 122. North America Furosemide Sales Price by Country (2021-2026) & (US$/kg) Table 123. North America Furosemide Sales Price by Country (2027-2032) & (US$/kg) Table 124. United States Furosemide Revenue (2021-2032) & (US$ Million) Table 125. Canada Furosemide Revenue (2021-2032) & (US$ Million) Table 126. Mexico Furosemide Revenue (2021-2032) & (US$ Million) Table 127. Europe Furosemide Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Furosemide Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Furosemide Sales by Type (2021-2026) & (tons) Table 130. Europe Furosemide Sales by Type (2027-2032) & (tons) Table 131. Europe Furosemide Sales Price by Type (2021-2026) & (US$/kg) Table 132. Europe Furosemide Sales Price by Type (2027-2032) & (US$/kg) Table 133. Europe Furosemide Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Furosemide Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Furosemide Sales by Application (2021-2026) & (tons) Table 136. Europe Furosemide Sales by Application (2027-2032) & (tons) Table 137. Europe Furosemide Sales Price by Application (2021-2026) & (US$/kg) Table 138. Europe Furosemide Sales Price by Application (2027-2032) & (US$/kg) Table 139. Europe Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Furosemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Furosemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Furosemide Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 143. Europe Furosemide Sales by Country (2021-2026) & (tons) Table 144. Europe Furosemide Sales by Country (2027-2032) & (tons) Table 145. Europe Furosemide Sales Price by Country (2021-2026) & (US$/kg) Table 146. Europe Furosemide Sales Price by Country (2027-2032) & (US$/kg) Table 147. Germany Furosemide Revenue (2021-2032) & (US$ Million) Table 148. France Furosemide Revenue (2021-2032) & (US$ Million) Table 149. U.K. Furosemide Revenue (2021-2032) & (US$ Million) Table 150. Italy Furosemide Revenue (2021-2032) & (US$ Million) Table 151. Russia Furosemide Revenue (2021-2032) & (US$ Million) Table 152. Spain Furosemide Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Furosemide Revenue (2021-2032) & (US$ Million) Table 154. Switzerland Furosemide Revenue (2021-2032) & (US$ Million) Table 155. Sweden Furosemide Revenue (2021-2032) & (US$ Million) Table 156. Poland Furosemide Revenue (2021-2032) & (US$ Million) Table 157. China Furosemide Revenue by Type (2021-2026) & (US$ Million) Table 158. China Furosemide Revenue by Type (2027-2032) & (US$ Million) Table 159. China Furosemide Sales by Type (2021-2026) & (tons) Table 160. China Furosemide Sales by Type (2027-2032) & (tons) Table 161. China Furosemide Sales Price by Type (2021-2026) & (US$/kg) Table 162. China Furosemide Sales Price by Type (2027-2032) & (US$/kg) Table 163. China Furosemide Revenue by Application (2021-2026) & (US$ Million) Table 164. China Furosemide Revenue by Application (2027-2032) & (US$ Million) Table 165. China Furosemide Sales by Application (2021-2026) & (tons) Table 166. China Furosemide Sales by Application (2027-2032) & (tons) Table 167. China Furosemide Sales Price by Application (2021-2026) & (US$/kg) Table 168. China Furosemide Sales Price by Application (2027-2032) & (US$/kg) Table 169. Asia Furosemide Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Furosemide Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Furosemide Sales by Type (2021-2026) & (tons) Table 172. Asia Furosemide Sales by Type (2027-2032) & (tons) Table 173. Asia Furosemide Sales Price by Type (2021-2026) & (US$/kg) Table 174. Asia Furosemide Sales Price by Type (2027-2032) & (US$/kg) Table 175. Asia Furosemide Revenue by Application (2021-2026) & (US$ Million) Table 176. Asia Furosemide Revenue by Application (2027-2032) & (US$ Million) Table 177. Asia Furosemide Sales by Application (2021-2026) & (tons) Table 178. Asia Furosemide Sales by Application (2027-2032) & (tons) Table 179. Asia Furosemide Sales Price by Application (2021-2026) & (US$/kg) Table 180. Asia Furosemide Sales Price by Application (2027-2032) & (US$/kg) Table 181. Asia Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia Furosemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Asia Furosemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Asia Furosemide Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 185. Asia Furosemide Sales by Country (2021-2026) & (tons) Table 186. Asia Furosemide Sales by Country (2027-2032) & (tons) Table 187. Asia Furosemide Sales Price by Country (2021-2026) & (US$/kg) Table 188. Asia Furosemide Sales Price by Country (2027-2032) & (US$/kg) Table 189. Japan Furosemide Revenue (2021-2032) & (US$ Million) Table 190. South Korea Furosemide Revenue (2021-2032) & (US$ Million) Table 191. India Furosemide Revenue (2021-2032) & (US$ Million) Table 192. Australia Furosemide Revenue (2021-2032) & (US$ Million) Table 193. Taiwan Furosemide Revenue (2021-2032) & (US$ Million) Table 194. Southeast Asia Furosemide Revenue (2021-2032) & (US$ Million) Table 195. SAMEA Furosemide Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Furosemide Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Furosemide Sales by Type (2021-2026) & (tons) Table 198. SAMEA Furosemide Sales by Type (2027-2032) & (tons) Table 199. SAMEA Furosemide Sales Price by Type (2021-2026) & (US$/kg) Table 200. SAMEA Furosemide Sales Price by Type (2027-2032) & (US$/kg) Table 201. SAMEA Furosemide Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Furosemide Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Furosemide Sales by Application (2021-2026) & (tons) Table 204. SAMEA Furosemide Sales by Application (2027-2032) & (tons) Table 205. SAMEA Furosemide Sales Price by Application (2021-2026) & (US$/kg) Table 206. SAMEA Furosemide Sales Price by Application (2027-2032) & (US$/kg) Table 207. SAMEA Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Furosemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. SAMEA Furosemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. SAMEA Furosemide Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 211. SAMEA Furosemide Sales by Country (2021-2026) & (tons) Table 212. SAMEA Furosemide Sales by Country (2027-2032) & (tons) Table 213. SAMEA Furosemide Sales Price by Country (2021-2026) & (US$/kg) Table 214. SAMEA Furosemide Sales Price by Country (2027-2032) & (US$/kg) Table 215. Brazil Furosemide Revenue (2021-2032) & (US$ Million) Table 216. Argentina Furosemide Revenue (2021-2032) & (US$ Million) Table 217. Chile Furosemide Revenue (2021-2032) & (US$ Million) Table 218. Colombia Furosemide Revenue (2021-2032) & (US$ Million) Table 219. Peru Furosemide Revenue (2021-2032) & (US$ Million) Table 220. Saudi Arabia Furosemide Revenue (2021-2032) & (US$ Million) Table 221. Israel Furosemide Revenue (2021-2032) & (US$ Million) Table 222. UAE Furosemide Revenue (2021-2032) & (US$ Million) Table 223. Turkey Furosemide Revenue (2021-2032) & (US$ Million) Table 224. Iran Furosemide Revenue (2021-2032) & (US$ Million) Table 225. Egypt Furosemide Revenue (2021-2032) & (US$ Million) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Furosemide Distributors List Table 229. Furosemide Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Furosemide Image Figure 2. Global Furosemide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furosemide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Solution Image Figure 6. Tablet Image Figure 7. Global Furosemide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Furosemide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinics Image Figure 10. Hospital Image Figure 11. Pharmacy Image Figure 12. Others Image Figure 13. Global Furosemide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Furosemide Revenue (2021-2032) & (US$ Million) Figure 15. Global Furosemide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Furosemide Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Furosemide Revenue Market Share by Region (2021-2032) Figure 18. Global Furosemide Sales (2021-2032) & (tons) Figure 19. Global Furosemide Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 20. Global Furosemide Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Furosemide Sales YoY (2021-2032) & (tons) Figure 22. Europe Furosemide Sales YoY (2021-2032) & (tons) Figure 23. China Furosemide Sales YoY (2021-2032) & (tons) Figure 24. Asia (Excluding China) Furosemide Sales YoY (2021-2032) & (tons) Figure 25. South America, Middle East and Africa Furosemide Sales YoY (2021-2032) & (tons) Figure 26. Global Furosemide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Furosemide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Furosemide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Furosemide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Furosemide Revenue Market Share by Type (2021-2032) Figure 32. Global Furosemide Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 33. Global Furosemide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Furosemide Sales Market Share by Type (2021-2032) Figure 35. Global Furosemide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Furosemide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Furosemide Revenue Market Share by Application (2021-2032) Figure 38. Global Furosemide Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 39. Global Furosemide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Furosemide Sales Market Share by Application (2021-2032) Figure 41. North America Furosemide Revenue Share by Type (2021-2032) Figure 42. North America Furosemide Sales Share by Type (2021-2032) Figure 43. North America Furosemide Revenue Share by Application (2021-2032) Figure 44. North America Furosemide Sales Share by Application (2021-2032) Figure 45. North America Furosemide Revenue Share by Country (2021-2032) Figure 46. North America Furosemide Sales Share by Country (2021-2032) Figure 47. Europe Furosemide Revenue Share by Type (2021-2032) Figure 48. Europe Furosemide Sales Share by Type (2021-2032) Figure 49. Europe Furosemide Revenue Share by Application (2021-2032) Figure 50. Europe Furosemide Sales Share by Application (2021-2032) Figure 51. Europe Furosemide Revenue Share by Country (2021-2032) Figure 52. Europe Furosemide Sales Share by Country (2021-2032) Figure 53. China Furosemide Revenue Share by Type (2021-2032) Figure 54. China Furosemide Sales Share by Type (2021-2032) Figure 55. China Furosemide Revenue Share by Application (2021-2032) Figure 56. China Furosemide Sales Share by Application (2021-2032) Figure 57. Asia Furosemide Revenue Share by Type (2021-2032) Figure 58. Asia Furosemide Sales Share by Type (2021-2032) Figure 59. Asia Furosemide Revenue Share by Application (2021-2032) Figure 60. Asia Furosemide Sales Share by Application (2021-2032) Figure 61. Asia Furosemide Revenue Share by Country (2021-2032) Figure 62. Asia Furosemide Sales Share by Country (2021-2032) Figure 63. SAMEA Furosemide Revenue Share by Type (2021-2032) Figure 64. SAMEA Furosemide Sales Share by Type (2021-2032) Figure 65. SAMEA Furosemide Revenue Share by Application (2021-2032) Figure 66. SAMEA Furosemide Sales Share by Application (2021-2032) Figure 67. SAMEA Furosemide Revenue Share by Country (2021-2032) Figure 68. SAMEA Furosemide Sales Share by Country (2021-2032) Figure 69. Furosemide Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Furosemide Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Solution
  • Tablet
Applications
  • Clinics
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Sun Pharm Inds
  • Sandoz
  • Sanofi Aventis
  • Mylan
  • West-Ward Pharms
  • US Pharm Holdings
  • Ivax Sub Teva Pharms
  • Hospira
  • Emcure Pharms

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Furosemide Market by Type
  3. 1.2.1 Global Furosemide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Solution
  6. 1.2.4 Tablet
  7. 1.3 Furosemide Market by Application
  8. 1.3.1 Global Furosemide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinics
  10. 1.3.3 Hospital
  11. 1.3.4 Pharmacy
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Furosemide Market Dynamics
  1. 2.1 Furosemide Industry Trends
  2. 2.2 Furosemide Industry Drivers
  3. 2.3 Furosemide Industry Opportunities and Challenges
  4. 2.4 Furosemide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Furosemide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Furosemide Revenue by Region
  3. 3.2.1 Global Furosemide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Furosemide Revenue by Region (2021-2026)
  5. 3.2.3 Global Furosemide Revenue by Region (2027-2032)
  6. 3.2.4 Global Furosemide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Furosemide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Furosemide Sales by Region
  9. 3.4.1 Global Furosemide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Furosemide Sales by Region (2021-2026)
  11. 3.4.3 Global Furosemide Sales by Region (2027-2032)
  12. 3.4.4 Global Furosemide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Furosemide Revenue by Manufacturers
  2. 4.1.1 Global Furosemide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Furosemide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Furosemide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Furosemide Sales by Manufacturers
  6. 4.2.1 Global Furosemide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Furosemide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Furosemide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Furosemide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Furosemide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Furosemide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Furosemide Manufacturers, Product Type & Application
  13. 4.7 Global Furosemide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Furosemide Market CR5 and HHI
  16. 4.8.2 2025 Furosemide Tier 1, Tier 2, and Tier 3
5 Furosemide Market by Type
  1. 5.1 Global Furosemide Revenue by Type
  2. 5.1.1 Global Furosemide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Furosemide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Furosemide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Furosemide Sales by Type
  6. 5.2.1 Global Furosemide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Furosemide Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Furosemide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Furosemide Price by Type
6 Furosemide Market by Application
  1. 6.1 Global Furosemide Revenue by Application
  2. 6.1.1 Global Furosemide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Furosemide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Furosemide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Furosemide Sales by Application
  6. 6.2.1 Global Furosemide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Furosemide Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Furosemide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Furosemide Price by Application
7 Company Profiles
  1. 7.1 Sun Pharm Inds
  2. 7.1.1 Sun Pharm Inds Company Information
  3. 7.1.2 Sun Pharm Inds Business Overview
  4. 7.1.3 Sun Pharm Inds Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharm Inds Furosemide Product Portfolio
  6. 7.1.5 Sun Pharm Inds Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Furosemide Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Sanofi Aventis
  14. 7.3.1 Sanofi Aventis Company Information
  15. 7.3.2 Sanofi Aventis Business Overview
  16. 7.3.3 Sanofi Aventis Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Aventis Furosemide Product Portfolio
  18. 7.3.5 Sanofi Aventis Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Furosemide Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 West-Ward Pharms
  26. 7.5.1 West-Ward Pharms Company Information
  27. 7.5.2 West-Ward Pharms Business Overview
  28. 7.5.3 West-Ward Pharms Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 West-Ward Pharms Furosemide Product Portfolio
  30. 7.5.5 West-Ward Pharms Recent Developments
  31. 7.6 US Pharm Holdings
  32. 7.6.1 US Pharm Holdings Company Information
  33. 7.6.2 US Pharm Holdings Business Overview
  34. 7.6.3 US Pharm Holdings Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 US Pharm Holdings Furosemide Product Portfolio
  36. 7.6.5 US Pharm Holdings Recent Developments
  37. 7.7 Ivax Sub Teva Pharms
  38. 7.7.1 Ivax Sub Teva Pharms Company Information
  39. 7.7.2 Ivax Sub Teva Pharms Business Overview
  40. 7.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ivax Sub Teva Pharms Furosemide Product Portfolio
  42. 7.7.5 Ivax Sub Teva Pharms Recent Developments
  43. 7.8 Hospira
  44. 7.8.1 Hospira Company Information
  45. 7.8.2 Hospira Business Overview
  46. 7.8.3 Hospira Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hospira Furosemide Product Portfolio
  48. 7.8.5 Hospira Recent Developments
  49. 7.9 Emcure Pharms
  50. 7.9.1 Emcure Pharms Company Information
  51. 7.9.2 Emcure Pharms Business Overview
  52. 7.9.3 Emcure Pharms Furosemide Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Emcure Pharms Furosemide Product Portfolio
  54. 7.9.5 Emcure Pharms Recent Developments
8 North America
  1. 8.1 North America Furosemide Market Size by Type
  2. 8.1.1 North America Furosemide Revenue by Type (2021-2032)
  3. 8.1.2 North America Furosemide Sales by Type (2021-2032)
  4. 8.1.3 North America Furosemide Price by Type (2021-2032)
  5. 8.2 North America Furosemide Market Size by Application
  6. 8.2.1 North America Furosemide Revenue by Application (2021-2032)
  7. 8.2.2 North America Furosemide Sales by Application (2021-2032)
  8. 8.2.3 North America Furosemide Price by Application (2021-2032)
  9. 8.3 North America Furosemide Market Size by Country
  10. 8.3.1 North America Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Furosemide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Furosemide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Furosemide Market Size by Type
  2. 9.1.1 Europe Furosemide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Furosemide Sales by Type (2021-2032)
  4. 9.1.3 Europe Furosemide Price by Type (2021-2032)
  5. 9.2 Europe Furosemide Market Size by Application
  6. 9.2.1 Europe Furosemide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Furosemide Sales by Application (2021-2032)
  8. 9.2.3 Europe Furosemide Price by Application (2021-2032)
  9. 9.3 Europe Furosemide Market Size by Country
  10. 9.3.1 Europe Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Furosemide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Furosemide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Furosemide Market Size by Type
  2. 10.1.1 China Furosemide Revenue by Type (2021-2032)
  3. 10.1.2 China Furosemide Sales by Type (2021-2032)
  4. 10.1.3 China Furosemide Price by Type (2021-2032)
  5. 10.2 China Furosemide Market Size by Application
  6. 10.2.1 China Furosemide Revenue by Application (2021-2032)
  7. 10.2.2 China Furosemide Sales by Application (2021-2032)
  8. 10.2.3 China Furosemide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Furosemide Market Size by Type
  2. 11.1.1 Asia Furosemide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Furosemide Sales by Type (2021-2032)
  4. 11.1.3 Asia Furosemide Price by Type (2021-2032)
  5. 11.2 Asia Furosemide Market Size by Application
  6. 11.2.1 Asia Furosemide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Furosemide Sales by Application (2021-2032)
  8. 11.2.3 Asia Furosemide Price by Application (2021-2032)
  9. 11.3 Asia Furosemide Market Size by Country
  10. 11.3.1 Asia Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Furosemide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Furosemide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Furosemide Market Size by Type
  2. 12.1.1 SAMEA Furosemide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Furosemide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Furosemide Price by Type (2021-2032)
  5. 12.2 SAMEA Furosemide Market Size by Application
  6. 12.2.1 SAMEA Furosemide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Furosemide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Furosemide Price by Application (2021-2032)
  9. 12.3 SAMEA Furosemide Market Size by Country
  10. 12.3.1 SAMEA Furosemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Furosemide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Furosemide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Furosemide Value Chain Analysis
  2. 13.1.1 Furosemide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Furosemide Production Mode & Process
  6. 13.2 Furosemide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Furosemide Distributors
  9. 13.2.3 Furosemide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst